ATI Pharmacology Practice Version 1 | 60 Questions | 2026/2027 Page 1
ATI PHARMACOLOGY PRACTICE VERSION 1
60 Questions and Answers with Rationale | LATEST
2026/2027 Aligned with Current ATI Pharmacology Proctored Exam Blueprint
Section 1: Pharmacokinetics and Pharmacodynamics (Q1-Q8)
Q1: A nurse is administering oral morphine to a client for postoperative pain. The client asks why the oral dose is higher
than the IV dose they received earlier. Which response by the nurse is most appropriate?
A. "Oral morphine is absorbed more slowly, so a higher dose is needed to achieve the same effect."
B. "Oral morphine has a longer half-life, so the body eliminates it faster."
C. "The kidneys filter out most of the oral dose before it can reach the site of action."
D. "The liver metabolizes a large portion of oral morphine before it reaches systemic circulation, reducing the amount
available." [CORRECT]
Correct Answer: D
Rationale: The correct answer is D. Oral morphine undergoes significant first-pass metabolism in the liver, where a large proportion is
metabolized before entering systemic circulation, resulting in lower bioavailability compared to IV administration. This is why higher oral doses
are required to achieve equivalent analgesic effects.
Q2: A nurse is preparing to administer two formulations of the same drug to different clients. Drug A has a bioavailability
of 40% and Drug B has a bioavailability of 90%. The nurse understands that which of the following best explains the
difference?
A. Drug B is administered via a route that has higher first-pass metabolism than Drug A.
B. Drug A has a larger volume of distribution than Drug B.
C. Drug B reaches the systemic circulation in a greater proportion of the administered dose. [CORRECT]
D. Drug A is more protein-bound than Drug B, reducing its active form.
Correct Answer: C
Rationale: The correct answer is C. Bioavailability refers to the fraction of an administered dose of unchanged drug that reaches the systemic
circulation. A higher bioavailability (90%) means Drug B reaches systemic circulation in a greater proportion than Drug A (40%), making more
drug available to produce its therapeutic effect. Option A is incorrect because higher first-pass metabolism would decrease, not increase,
bioavailability.
Q3: A client who has been taking carbamazepine for seizure management is newly prescribed warfarin for atrial
fibrillation. The nurse anticipates that which of the following will occur?
A. The warfarin dose will need to be increased due to reduced warfarin effects. [CORRECT]
B. The warfarin dose will need to be decreased due to increased warfarin effects.
C. Carbamazepine levels will increase due to warfarin interaction.
D. The client will be at increased risk for warfarin toxicity.
Correct Answer: A
Rationale: The correct answer is A. Carbamazepine is a potent CYP450 enzyme inducer that increases the metabolism of warfarin through
CYP2C9 and CYP3A4 pathways, reducing warfarin's therapeutic effect and requiring a higher dose to achieve the target INR. Options B and D
describe the opposite effect, which would occur with a CYP450 inhibitor.
Q4: A nurse is reviewing the medication list of a client who is being admitted to the hospital. The client takes both warfarin
and sulfamethoxazole-trimethoprim. The nurse should recognize that this combination increases the client's risk for which
of the following?
A. Therapeutic failure of the antibiotic due to warfarin interference.
B. Decreased warfarin absorption leading to subtherapeutic INR.
C. Accelerated renal clearance of both medications.
D. Increased risk of bleeding due to inhibition of warfarin metabolism. [CORRECT]
ATI Pharmacology Proctored Exam Preparation
, ATI Pharmacology Practice Version 1 | 60 Questions | 2026/2027 Page 2
Correct Answer: D
Rationale: The correct answer is D. Sulfamethoxazole-trimethoprim is a CYP450 enzyme inhibitor (particularly CYP2C9) that reduces the
metabolism of warfarin, leading to elevated warfarin levels and an increased risk of bleeding. The nurse should monitor the INR closely and
assess for signs of bleeding.
Q5: A nurse is caring for an older adult client who takes highly protein-bound medications including warfarin and
phenytoin. The provider prescribes sulfamethoxazole, which is also highly protein-bound. The nurse should monitor the
client for which of the following?
A. Decreased effects of warfarin and phenytoin as they are displaced from protein-binding sites.
B. Rapid renal excretion of sulfamethoxazole due to competition for binding sites.
C. No interaction, because only medications in the same drug class compete for binding sites.
D. Increased free (unbound) concentrations of warfarin and phenytoin, increasing the risk of toxicity. [CORRECT]
Correct Answer: D
Rationale: The correct answer is D. Sulfamethoxazole can displace warfarin and phenytoin from plasma protein-binding sites, increasing the
free (active) concentrations and raising the risk for toxicity such as bleeding and CNS effects. Only the unbound fraction of a drug is
pharmacologically active. Option A is the opposite of what occurs.
Q6: A nurse is caring for a client receiving digoxin therapy. The nurse knows that digoxin has a narrow therapeutic index.
Which of the following is the priority nursing action related to this characteristic?
A. Administer the medication with food to enhance absorption.
B. Teach the client to double the dose if a dose is missed.
C. Encourage the client to take over-the-counter potassium supplements.
D. Monitor for signs of both subtherapeutic and toxic effects, and check serum drug levels regularly. [CORRECT]
Correct Answer: D
Rationale: The correct answer is D. A narrow therapeutic index means the difference between a therapeutic and toxic dose is very small,
requiring close monitoring of serum drug levels, vital signs, and clinical response. Digoxin has a therapeutic range of 0.8 to 2.0 ng/mL, and
levels above this range can cause life-threatening toxicity. Option B is dangerous and could lead to toxicity.
Q7: A nurse is calculating when a medication will reach steady state. The medication has a half-life of 12 hours.
Approximately how long will it take for this drug to reach steady-state concentration?
A. 12 hours
B. 24 hours
C. 48 hours
D. 60 hours [CORRECT]
Correct Answer: D
Rationale: The correct answer is D. It takes approximately 4 to 5 half-lives for a medication to reach steady-state concentration in the body.
With a half-life of 12 hours, 5 half-lives equals 60 hours. At steady state, the rate of drug administration equals the rate of drug elimination, and
serum concentrations remain relatively stable.
Q8: A nurse is administering phenytoin to a client with a seizure disorder. The nurse should understand that phenytoin
follows which type of pharmacokinetic elimination?
A. First-order kinetics, where a constant fraction of the drug is eliminated per unit time.
B. Zero-order kinetics, where a constant amount of the drug is eliminated per unit time regardless of serum concentration.
[CORRECT]
C. Nonlinear kinetics that convert to first-order at high doses.
D. Saturable kinetics only during renal impairment.
Correct Answer: B
Rationale: The correct answer is B. Phenytoin follows zero-order (saturable) kinetics, meaning a constant amount of drug is eliminated per unit
time rather than a constant fraction. At therapeutic doses, the liver enzymes responsible for phenytoin metabolism become saturated, so small
increases in dose can lead to disproportionately large increases in serum concentration and toxicity. Option A describes first-order kinetics,
which is incorrect for phenytoin.
Section 2: Cardiovascular and Renal Pharmacology (Q9-Q18)
ATI Pharmacology Proctored Exam Preparation
ATI PHARMACOLOGY PRACTICE VERSION 1
60 Questions and Answers with Rationale | LATEST
2026/2027 Aligned with Current ATI Pharmacology Proctored Exam Blueprint
Section 1: Pharmacokinetics and Pharmacodynamics (Q1-Q8)
Q1: A nurse is administering oral morphine to a client for postoperative pain. The client asks why the oral dose is higher
than the IV dose they received earlier. Which response by the nurse is most appropriate?
A. "Oral morphine is absorbed more slowly, so a higher dose is needed to achieve the same effect."
B. "Oral morphine has a longer half-life, so the body eliminates it faster."
C. "The kidneys filter out most of the oral dose before it can reach the site of action."
D. "The liver metabolizes a large portion of oral morphine before it reaches systemic circulation, reducing the amount
available." [CORRECT]
Correct Answer: D
Rationale: The correct answer is D. Oral morphine undergoes significant first-pass metabolism in the liver, where a large proportion is
metabolized before entering systemic circulation, resulting in lower bioavailability compared to IV administration. This is why higher oral doses
are required to achieve equivalent analgesic effects.
Q2: A nurse is preparing to administer two formulations of the same drug to different clients. Drug A has a bioavailability
of 40% and Drug B has a bioavailability of 90%. The nurse understands that which of the following best explains the
difference?
A. Drug B is administered via a route that has higher first-pass metabolism than Drug A.
B. Drug A has a larger volume of distribution than Drug B.
C. Drug B reaches the systemic circulation in a greater proportion of the administered dose. [CORRECT]
D. Drug A is more protein-bound than Drug B, reducing its active form.
Correct Answer: C
Rationale: The correct answer is C. Bioavailability refers to the fraction of an administered dose of unchanged drug that reaches the systemic
circulation. A higher bioavailability (90%) means Drug B reaches systemic circulation in a greater proportion than Drug A (40%), making more
drug available to produce its therapeutic effect. Option A is incorrect because higher first-pass metabolism would decrease, not increase,
bioavailability.
Q3: A client who has been taking carbamazepine for seizure management is newly prescribed warfarin for atrial
fibrillation. The nurse anticipates that which of the following will occur?
A. The warfarin dose will need to be increased due to reduced warfarin effects. [CORRECT]
B. The warfarin dose will need to be decreased due to increased warfarin effects.
C. Carbamazepine levels will increase due to warfarin interaction.
D. The client will be at increased risk for warfarin toxicity.
Correct Answer: A
Rationale: The correct answer is A. Carbamazepine is a potent CYP450 enzyme inducer that increases the metabolism of warfarin through
CYP2C9 and CYP3A4 pathways, reducing warfarin's therapeutic effect and requiring a higher dose to achieve the target INR. Options B and D
describe the opposite effect, which would occur with a CYP450 inhibitor.
Q4: A nurse is reviewing the medication list of a client who is being admitted to the hospital. The client takes both warfarin
and sulfamethoxazole-trimethoprim. The nurse should recognize that this combination increases the client's risk for which
of the following?
A. Therapeutic failure of the antibiotic due to warfarin interference.
B. Decreased warfarin absorption leading to subtherapeutic INR.
C. Accelerated renal clearance of both medications.
D. Increased risk of bleeding due to inhibition of warfarin metabolism. [CORRECT]
ATI Pharmacology Proctored Exam Preparation
, ATI Pharmacology Practice Version 1 | 60 Questions | 2026/2027 Page 2
Correct Answer: D
Rationale: The correct answer is D. Sulfamethoxazole-trimethoprim is a CYP450 enzyme inhibitor (particularly CYP2C9) that reduces the
metabolism of warfarin, leading to elevated warfarin levels and an increased risk of bleeding. The nurse should monitor the INR closely and
assess for signs of bleeding.
Q5: A nurse is caring for an older adult client who takes highly protein-bound medications including warfarin and
phenytoin. The provider prescribes sulfamethoxazole, which is also highly protein-bound. The nurse should monitor the
client for which of the following?
A. Decreased effects of warfarin and phenytoin as they are displaced from protein-binding sites.
B. Rapid renal excretion of sulfamethoxazole due to competition for binding sites.
C. No interaction, because only medications in the same drug class compete for binding sites.
D. Increased free (unbound) concentrations of warfarin and phenytoin, increasing the risk of toxicity. [CORRECT]
Correct Answer: D
Rationale: The correct answer is D. Sulfamethoxazole can displace warfarin and phenytoin from plasma protein-binding sites, increasing the
free (active) concentrations and raising the risk for toxicity such as bleeding and CNS effects. Only the unbound fraction of a drug is
pharmacologically active. Option A is the opposite of what occurs.
Q6: A nurse is caring for a client receiving digoxin therapy. The nurse knows that digoxin has a narrow therapeutic index.
Which of the following is the priority nursing action related to this characteristic?
A. Administer the medication with food to enhance absorption.
B. Teach the client to double the dose if a dose is missed.
C. Encourage the client to take over-the-counter potassium supplements.
D. Monitor for signs of both subtherapeutic and toxic effects, and check serum drug levels regularly. [CORRECT]
Correct Answer: D
Rationale: The correct answer is D. A narrow therapeutic index means the difference between a therapeutic and toxic dose is very small,
requiring close monitoring of serum drug levels, vital signs, and clinical response. Digoxin has a therapeutic range of 0.8 to 2.0 ng/mL, and
levels above this range can cause life-threatening toxicity. Option B is dangerous and could lead to toxicity.
Q7: A nurse is calculating when a medication will reach steady state. The medication has a half-life of 12 hours.
Approximately how long will it take for this drug to reach steady-state concentration?
A. 12 hours
B. 24 hours
C. 48 hours
D. 60 hours [CORRECT]
Correct Answer: D
Rationale: The correct answer is D. It takes approximately 4 to 5 half-lives for a medication to reach steady-state concentration in the body.
With a half-life of 12 hours, 5 half-lives equals 60 hours. At steady state, the rate of drug administration equals the rate of drug elimination, and
serum concentrations remain relatively stable.
Q8: A nurse is administering phenytoin to a client with a seizure disorder. The nurse should understand that phenytoin
follows which type of pharmacokinetic elimination?
A. First-order kinetics, where a constant fraction of the drug is eliminated per unit time.
B. Zero-order kinetics, where a constant amount of the drug is eliminated per unit time regardless of serum concentration.
[CORRECT]
C. Nonlinear kinetics that convert to first-order at high doses.
D. Saturable kinetics only during renal impairment.
Correct Answer: B
Rationale: The correct answer is B. Phenytoin follows zero-order (saturable) kinetics, meaning a constant amount of drug is eliminated per unit
time rather than a constant fraction. At therapeutic doses, the liver enzymes responsible for phenytoin metabolism become saturated, so small
increases in dose can lead to disproportionately large increases in serum concentration and toxicity. Option A describes first-order kinetics,
which is incorrect for phenytoin.
Section 2: Cardiovascular and Renal Pharmacology (Q9-Q18)
ATI Pharmacology Proctored Exam Preparation
